
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target by at least one …